Cookie Settings
We use cookies to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement and Cookie Statement.
Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. |
Unseparated fraction | Cells depleted of |
CD209 (DC-SIGN) MicroBead Kit, humanFigure 1Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. | CD209 (DC-SIGN) MicroBead Kit, humanFigure 1Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. |
Isolated CD209 (DC-SIGN) + cells | |
CD209 (DC-SIGN) MicroBead Kit, humanFigure 1Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. |
Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. |
Unseparated fraction | Cells depleted of |
CD209 (DC-SIGN) MicroBead Kit, humanFigure 1Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. | CD209 (DC-SIGN) MicroBead Kit, humanFigure 1Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. |
Isolated CD209 (DC-SIGN) + cells | |
CD209 (DC-SIGN) MicroBead Kit, humanFigure 1Separation of CD209 + cells from human PBMCs spiked with 1% Mo-DCs using the CD209 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator. Mo-DCs were generated in vitro with GM-CSF and IL-4 for 7 days. Cells were stained with CD209 (DC-SIGN)-FITC and CD304 (BDCA-4/Neuropilin-1)-PE and analyzed by flow cytometry. |
Seems like you are coming from USA!
Do you want to visit our website in your country?
Copyright © 2023 Miltenyi Biotec and/or its affiliates. All rights reserved.